Holen Sie sich die Stockscreener-App
0.801
3.62%
0.028
Handel nachbörslich:
.81
0.009
+1.12%
Fractyl Health Inc Aktie (GUTS) Neueste Nachrichten
Fractyl Health Inc (GUTS) Cash Flow - TradingKey
Fractyl Health Inc (GUTS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Fractyl Health Market Sentiment - Benzinga España
GUTS|Fractyl Health Inc|Price:0.773|Chg%:+0.016 - TradingKey
Enterprise value to revenue forward of Fractyl Health, Inc. – NASDAQ:GUTS - TradingView
Fractyl Health Inc (GUTS) Institutional Confidence - TradingKey
Fractyl Health CEO to present at key biotech investor conferences in July and August 2026 - Pluang
Fractyl Health CEO to Join Meetings and Aug. 12 Fireside Chat - Stock Titan
Fractyl Health stock up on encouraging one-year Revita study results - MSN
Fractyl Health helps maintain weight after stopping popular obesity drugs, stock soars - MSN
Fractyl Health (GUTS) AGM 2026 Summary - Quartr
Fractyl Health (GUTS) Morgan Stanley 22nd Annual Global Healthcare Conference summary - Quartr
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Fractyl Health, Inc. (GUTS) - The Globe and Mail
Price to sales forward of Fractyl Health, Inc. – NASDAQ:GUTS - TradingView
Morgan Stanley Maintains Fractyl Health(GUTS.US) With Hold Rating, Maintains Target Price $2 - Moomoo
CCORF Maintains Fractyl Health(GUTS.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Craig-Hallum Maintains Fractyl Health(GUTS.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Analysts Are Bullish on Top Healthcare Stocks: Fractyl Health, Inc. (GUTS), AbbVie (ABBV) - The Globe and Mail
Fractyl Health Stock Up on Encouraging One-Year Revita Study Results - Yahoo Finance
Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation - Sahm
Fractyl Health Helps Maintain Weight After Stopping Popular Obesity Drugs, Stock Soars - Sahm
Fractyl Health reports positive randomized data from REMAIN-1 Midpoint Cohort demonstrating durable weight maintenance one year after GLP-1 discontinuation - News-Medical
H.C. Wainwright reiterates Buy on Fractyl Health stock at $8 - Investing.com UK
H.C. Wainwright reiterates Buy on Fractyl Health stock at $8 By Investing.com - Investing.com South Africa
Fractyl Health reports one-year data from weight maintenance trial - Investing.com UK
Morgan Stanley reiterates Fractyl Health stock rating on weight maintenance data - Investing.com
Fractyl Health’s Revita Procedure Shows 84% Weight Loss Maintenance One Year After GLP-1 Discontinuation in REMAIN-1 Study – Minichart - Minichart
Fractyl gains after data for Revita procedure (GUTS:NASDAQ) - Seeking Alpha
Fractyl reports 7.8 percent weight regain with Revita - grafa.com
Fractyl Health reports one-year data from weight maintenance trial By Investing.com - Investing.com South Africa
GUTS: Revita maintains up to 84% of GLP-1-induced weight loss at one year with strong safety - TradingView
Fractyl Health Says Revita Helped Patients Keep Weight Off After Stopping GLP-1s - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Intraday Session - Sahm
GUTS: Revita enabled up to 84% weight loss retention one year after GLP-1 discontinuation - TradingView
Fractyl Health (Nasdaq: GUTS) reports 1-year Revita weight maintenance data - Stock Titan
Fractyl Health Reports Positive Randomized Data from - GlobeNewswire
Price to book forward of Fractyl Health, Inc. – NASDAQ:GUTS - TradingView
Number of shareholders of Fractyl Health, Inc. – NASDAQ:GUTS - TradingView
Fractyl Health (GUTS) Slides 3.9% as Biotech Stock Tests Support Near $0.72Force Index - dars.gov.et
Fractyl Health (GUTS) Slides 3.9% as Shares Approach Critical Support at $0.72Ichimoku Cloud - dars.gov.et
Fractyl Health (GUTS) Stock Sees Fair Value Cut As Analysts Weigh Revita Opportunity - Yahoo Finance
Fractyl Health (GUTS) Q1 2026 Earnings: Wider-than-Expected Loss, No Revenue, Shares SlipFree Cash Flow Trends - dars.gov.et
Fractyl Health (GUTS) Tests Support Near $0.76 as Downside Pressure PersistsDealer Delta - dars.gov.et
GUTSFractyl Health Inc Options - Finviz
Fractyl Health Price Target Announced at $4.00/Share by Craig-Hallum - Moomoo
GUTS Q1 2026 Earnings: EPS Surprise Beats Estimates Amid Pre-Revenue Clinical ProgressQuarterly Financial Update - dars.gov.et
GUTS Initiates Coverage by Fractyl Health -- Price Target Set at $4.00 - GuruFocus
Fractyl Health Initiated at Buy by Craig-Hallum - Moomoo
Craig-Hallum initiates Fractyl Health stock coverage with buy rating By Investing.com - Investing.com India
Craig-Hallum initiates Fractyl Health stock coverage with buy rating - Investing.com
Craig-Hallum Initiates Fractyl Health at Buy With $4 Price Target - Moomoo
Fractyl Health, Inc. Actuals & Estimates (NASDAQ:GUTS) - TradingView
GUTS Forecast — Price Target — Prediction for 2027 - TradingView
FRACTYL HEALTH INC (GUTS) Stock Chart - ChartMill
GUTS Q1 2026 Earnings: EPS Beat Amid Pre-Revenue Stage; Stock Declines 4.4%GAAP Earnings Report - Město Břeclav
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):